Copper(2+)
copper(2+) (Cu²⁺), commonly called the cupric ion, is the divalent cation of the transition metal copper and the predominant oxidation state of copper in extracellular biological fluids.
copper(2+) (Cu²⁺), commonly called the cupric ion, is the divalent cation of the transition metal copper and the predominant oxidation state of copper in extracellular biological fluids. As an essential trace element, copper serves as a catalytic cofactor for metalloenzymes involved in mitochondrial respiration, antioxidant defense, iron mobilization, and connective tissue cross-linking. Because free ionic copper is toxic, its distribution is tightly controlled by membrane transporters, ATPase copper-transporting proteins, and intracellular copper chaperones, which keep the unbound cytosolic pool vanishingly small. glutathione and other thiols buffer the labile fraction. Disturbed copper handling has been linked to neurodegenerative conditions such as Alzheimer's disease, where Cu²⁺ binds amyloid beta (Aβ), as well as to cancer, insulin resistance, and cardiovascular disease.
The defining chemical property of Cu²⁺ is its redox activity: cycling between the cupric (Cu²⁺) and cuprous (Cu⁺) states allows it to react with hydrogen peroxide in Fenton-like chemistry, generating reactive oxygen species that damage lipids, proteins, and nucleic acids and impose oxidative stress. This same reactivity is exploited therapeutically. copper overload triggers cuproptosis, a copper-dependent form of cell death distinct from apoptosis and ferroptosis that proceeds through mitochondrial lipoylated-protein aggregation and depends on ferredoxin 1 (FDX1); related strategies deplete glutathione or engage the Nrf2/GPx4 axis and the cGAS-STING pathway to sensitize tumors and support cancer immunotherapy. In materials chemistry, Cu²⁺ acts as a coordinating node: it templates metal-organic frameworks and histidine-containing peptide metallogels used as drug carriers, and copper-based nanozymes display peroxidase-like catalytic activity that is harnessed for signal amplification in electrochemical biosensors. Cu²⁺ is likewise a common analytical target as an environmental heavy-metal contaminant, detected by CRISPR-Cas12a and nanomaterial platforms or removed by cellulose-based adsorbent hydrogels, and its antimicrobial oxidative activity is active against organisms including Staphylococcus aureus and Pseudomonas aeruginosa.
Where the papers sit
21 papers from the last 6 months study copper(2+) directly · updated from PubMed 7 Oct 2026
Study type 1 clinical trial · 1 observational · 4 human data · 14 preclinical · 1 unclassified
Themes one subject · 1 paradigm shift · 1 new direction
Those 21 are all about one subject.
-
Copper in Health and Environment
Copper research here spans biosensing, environmental surveillance, nanomedicine, antimicrobial activity and metal-balance disorders. Nanozymes, MOF frameworks and copper-based assemblies recur as tools for signal amplification, targeted delivery, photothermal therapy and cuproptosis. Clinical work addresses Wilson disease and associations between copper and polycystic ovary syndrome, while other studies examine biobank quality and antibody-product impurities. The set shares copper-centered applications but shows no single biological question or overall direction.
Therapeutic benefit can come from sequestering copper(2+) rather than increasing its intracellular availability
The Alzheimer’s disease study of NGN-CDs and the cancer study of rationally designed Schiff-base copper chelators independently treat bioavailable Cu2+ as a pathological liability rather than a therapeutic payload. NGN-CDs chelate Cu2+, thereby blocking Cu2+-induced amyloid-β aggregation and reactive oxygen species generation, while the Schiff-base chelator 2d depletes copper, disrupts redox homeostasis, and induces tumor-cell necroptosis 42003377Apr 41995077Apr. This reverses the copper-overload strategy used by many of the set’s therapeutic nanoplatforms: copper removal or sequestration, not copper delivery, becomes the operative intervention in these disease models.
Leachable copper(2+) is identified as a hidden manufacturing hazard that can fragment therapeutic antibodies
The therapeutic-antibody developability study examines complex antibody formats exposed to phosphate-buffered saline during automated buffer exchange and finds that the observed fragmentation is not an intrinsic protein defect. Instead, phosphate mobilizes trace catalytic copper from disposable chromatography columns; the leached copper coordinates the antibody hinge and drives localized Fenton-like oxidative cleavage, with 2 + 1 CrossMabs especially vulnerable 42125798May. This assigns Cu2+ a distinct role as a purification-process impurity and quality-control determinant, changing antibody stability assessment from an evaluation of molecular properties alone to one that also accounts for metal contamination from processing materials.
Papers
The 21 papers from the last 6 months that study copper(2+) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Copper in Health and Environment (21)
- Exploiting amino acid-modulated active sites of Cu-MOF nanozyme for signal-amplified electrochemical aptasensing of cardiac troponin I. Mikrochimica acta · 15 Jul 2026 PMID 42455351
- Label-Free Electrochemical CRISPR Platform Gated by Allosteric Transcription Factors for Ultrasensitive Small-Molecule Detection. Analytical chemistry · 3 Jul 2026 PMID 42393911
- A real-time microfluidic surveillance system for multiplex detection of heavy metal contamination in wastewater. Lab on a chip · 1 Jul 2026 PMID 42381600
- Impact of long-term cryopreservation on serum proteome and metallome: Implications for Biobank quality control. PloS one · 25 Jun 2026 PMID 42348576
- Tumor-targeting semi-rigid metal-organic-polymer framework nanoparticles with high adaptability and bioavailability. Journal of materials chemistry. B · 23 Jun 2026 PMID 42333417
- Aromatic/aliphatic residue balance regulates Cu(II)-induced supramolecular gel formation and drug release in histidine-containing tetrapeptides. Soft matter · 16 Jun 2026 PMID 42300085
- Copper ions restore antibacterial activity of tigecycline by regulating photodegradation pathway under light exposure‌. Communications biology · 29 May 2026 PMID 42215682
- Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial. Hepatology communications · 19 May 2026 PMID 42155004
- Self-enhanced copper-doped Prussian blue nanoplatform for amplifying enzyme-like activity and photothermal effects. International journal of pharmaceutics · 16 May 2026 PMID 42142675
- Association of serum levels of zinc and copper with pathophysiological features of polycystic ovary syndrome. African journal of reproductive health · 15 May 2026 PMID 42137979
- CaO2-Powered Nanomotors with Enhanced Cellular Uptake and Lysosomal Escape for Cuproptosis and Reactive Oxygen Species-Mediated Synergistic Cancer Therapy. ACS applied materials & interfaces · 13 May 2026 PMID 42126988
- Impact of process impurities on developability assessments of complex antibody formats: the striking role of leachable copper. mAbs · 13 May 2026 PMID 42125798
- DNA-Antibody Conjugation Clamp-Mediated Coordination Quenching for the Ratiometric Detection of CA242. Analytical chemistry · 2 May 2026 PMID 42068271
- Preparation of CPD12C15 hyaluronic acid nanoparticles, a novel glycolytic inhibitor and preliminary pharmacologic study on anti-pancreatic cancer. International journal of pharmaceutics · 29 Apr 2026 PMID 42055152
- Self-Cascading Copper-Based Nanoassemblies Trigger Bacterial Cuproptosis-Like Death and Promote Wound Healing for Diabetic Drug-Resistant Bacterial Infections. ACS nano · 29 Apr 2026 PMID 42054707
- GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation. Molecular pharmaceutics · 27 Apr 2026 PMID 42044237
- Core-Satellite Structured Copper-Based Nanomedicine for Orchestrating Accelerated Wound Healing with Potent Antibacterial Efficacy. ACS applied materials & interfaces · 20 Apr 2026 PMID 42003695
- A Swiss army knife for the treatment of bone cancers: a new multifunctional platform based upon SPIONs@copper-doped bioactive glass core-shell nanoparticles. Nanoscale · 20 Apr 2026 PMID 42003487
- Five-in-One Neurodetoxification-Guardian-Type Near-Infrared Carbon Dots for Synergistic Blockade of Alzheimer's Disease Pathological Cascade. Analytical chemistry · 20 Apr 2026 PMID 42003377
- Glutathione-depleting mitochondria-targeting nanodrugs for stress amplification and immune activation via synergistic photodynamic therapy and cuproptosis. Acta biomaterialia · 19 Apr 2026 PMID 42002062
- Rational Design of Schiff Base Copper Chelators as Potent Necroptosis Inducers for Anticancer Therapy. Journal of medicinal chemistry · 17 Apr 2026 PMID 41995077
By study type
Clinical trials (1)
- Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial. Hepatology communications · 19 May 2026 PMID 42155004
Observational studies and case reports (1)
- Association of serum levels of zinc and copper with pathophysiological features of polycystic ovary syndrome. African journal of reproductive health · 15 May 2026 PMID 42137979
Human data, design not indexed (4)
- Exploiting amino acid-modulated active sites of Cu-MOF nanozyme for signal-amplified electrochemical aptasensing of cardiac troponin I. Mikrochimica acta · 15 Jul 2026 PMID 42455351
- Impact of long-term cryopreservation on serum proteome and metallome: Implications for Biobank quality control. PloS one · 25 Jun 2026 PMID 42348576
- Impact of process impurities on developability assessments of complex antibody formats: the striking role of leachable copper. mAbs · 13 May 2026 PMID 42125798
- DNA-Antibody Conjugation Clamp-Mediated Coordination Quenching for the Ratiometric Detection of CA242. Analytical chemistry · 2 May 2026 PMID 42068271
Preclinical: animal, cell and lab studies (14)
- Label-Free Electrochemical CRISPR Platform Gated by Allosteric Transcription Factors for Ultrasensitive Small-Molecule Detection. Analytical chemistry · 3 Jul 2026 PMID 42393911
- A real-time microfluidic surveillance system for multiplex detection of heavy metal contamination in wastewater. Lab on a chip · 1 Jul 2026 PMID 42381600
- Tumor-targeting semi-rigid metal-organic-polymer framework nanoparticles with high adaptability and bioavailability. Journal of materials chemistry. B · 23 Jun 2026 PMID 42333417
- Aromatic/aliphatic residue balance regulates Cu(II)-induced supramolecular gel formation and drug release in histidine-containing tetrapeptides. Soft matter · 16 Jun 2026 PMID 42300085
- Self-enhanced copper-doped Prussian blue nanoplatform for amplifying enzyme-like activity and photothermal effects. International journal of pharmaceutics · 16 May 2026 PMID 42142675
- CaO2-Powered Nanomotors with Enhanced Cellular Uptake and Lysosomal Escape for Cuproptosis and Reactive Oxygen Species-Mediated Synergistic Cancer Therapy. ACS applied materials & interfaces · 13 May 2026 PMID 42126988
- Preparation of CPD12C15 hyaluronic acid nanoparticles, a novel glycolytic inhibitor and preliminary pharmacologic study on anti-pancreatic cancer. International journal of pharmaceutics · 29 Apr 2026 PMID 42055152
- Self-Cascading Copper-Based Nanoassemblies Trigger Bacterial Cuproptosis-Like Death and Promote Wound Healing for Diabetic Drug-Resistant Bacterial Infections. ACS nano · 29 Apr 2026 PMID 42054707
- GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation. Molecular pharmaceutics · 27 Apr 2026 PMID 42044237
- Core-Satellite Structured Copper-Based Nanomedicine for Orchestrating Accelerated Wound Healing with Potent Antibacterial Efficacy. ACS applied materials & interfaces · 20 Apr 2026 PMID 42003695
- A Swiss army knife for the treatment of bone cancers: a new multifunctional platform based upon SPIONs@copper-doped bioactive glass core-shell nanoparticles. Nanoscale · 20 Apr 2026 PMID 42003487
- Five-in-One Neurodetoxification-Guardian-Type Near-Infrared Carbon Dots for Synergistic Blockade of Alzheimer's Disease Pathological Cascade. Analytical chemistry · 20 Apr 2026 PMID 42003377
- Glutathione-depleting mitochondria-targeting nanodrugs for stress amplification and immune activation via synergistic photodynamic therapy and cuproptosis. Acta biomaterialia · 19 Apr 2026 PMID 42002062
- Rational Design of Schiff Base Copper Chelators as Potent Necroptosis Inducers for Anticancer Therapy. Journal of medicinal chemistry · 17 Apr 2026 PMID 41995077
Unclassified: not yet indexed with MeSH (1)
- Copper ions restore antibacterial activity of tigecycline by regulating photodegradation pathway under light exposure‌. Communications biology · 29 May 2026 PMID 42215682
Written from 21 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-08-26 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.